It is worth noting that bevacizumab associated with these two VEGF blockade of signal increased CD163+ dendritic cells trafficking, and CD8+ t cells across the trafficking of tumor blood vessels, and not just by ipiliumumab 196. The gene discussed is CD163; the disease is neoplasm.